GB201016880D0 - Phosphodiesterase inhibitors - Google Patents

Phosphodiesterase inhibitors

Info

Publication number
GB201016880D0
GB201016880D0 GBGB1016880.5A GB201016880A GB201016880D0 GB 201016880 D0 GB201016880 D0 GB 201016880D0 GB 201016880 A GB201016880 A GB 201016880A GB 201016880 D0 GB201016880 D0 GB 201016880D0
Authority
GB
United Kingdom
Prior art keywords
phosphodiesterase inhibitors
phosphodiesterase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1016880.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIOTECH PHARMACEUTICALS Ltd
Original Assignee
RIOTECH PHARMACEUTICALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIOTECH PHARMACEUTICALS Ltd filed Critical RIOTECH PHARMACEUTICALS Ltd
Priority to GBGB1016880.5A priority Critical patent/GB201016880D0/en
Publication of GB201016880D0 publication Critical patent/GB201016880D0/en
Priority to PCT/GB2011/051872 priority patent/WO2012046030A2/en
Ceased legal-status Critical Current

Links

GBGB1016880.5A 2010-10-07 2010-10-07 Phosphodiesterase inhibitors Ceased GB201016880D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1016880.5A GB201016880D0 (en) 2010-10-07 2010-10-07 Phosphodiesterase inhibitors
PCT/GB2011/051872 WO2012046030A2 (en) 2010-10-07 2011-10-03 Phosphodiesterase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1016880.5A GB201016880D0 (en) 2010-10-07 2010-10-07 Phosphodiesterase inhibitors

Publications (1)

Publication Number Publication Date
GB201016880D0 true GB201016880D0 (en) 2010-11-17

Family

ID=43243648

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1016880.5A Ceased GB201016880D0 (en) 2010-10-07 2010-10-07 Phosphodiesterase inhibitors

Country Status (2)

Country Link
GB (1) GB201016880D0 (en)
WO (1) WO2012046030A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8440693B2 (en) 2009-12-22 2013-05-14 Novartis Ag Substituted isoquinolinones and quinazolinones
JP5992054B2 (en) 2011-11-29 2016-09-14 ノバルティス アーゲー Pyrazolopyrrolidine compound
JO3357B1 (en) 2012-01-26 2019-03-13 Novartis Ag Imidazopyrrolidinone compounds
US9365576B2 (en) 2012-05-24 2016-06-14 Novartis Ag Pyrrolopyrrolidinone compounds
EP2948453B1 (en) 2013-01-22 2017-08-02 Novartis AG Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
WO2014115077A1 (en) 2013-01-22 2014-07-31 Novartis Ag Substituted purinone compounds
CN103819476B (en) * 2013-03-05 2016-08-17 中国人民解放军第二军医大学 Pyrrolidone pyrazole compound and the purposes as medicine thereof
MX2015016344A (en) 2013-05-27 2016-03-01 Novartis Ag Imidazopyrrolidinone derivatives and their use in the treatment of disease.
US8975417B2 (en) 2013-05-27 2015-03-10 Novartis Ag Pyrazolopyrrolidine derivatives and their use in the treatment of disease
CA2912986A1 (en) * 2013-05-28 2014-12-04 Novartis Ag Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
AU2014272700B2 (en) 2013-05-28 2016-12-01 Novartis Ag Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
WO2015075665A1 (en) 2013-11-21 2015-05-28 Novartis Ag Pyrrolopyrrolone derivatives and their use as bet inhibitors
CN104876936B (en) * 2015-05-25 2018-01-30 中国人民解放军第二军医大学 The preparation of pyrrolones and pyrazole compound and the purposes as medicine
BR112020012374A2 (en) * 2017-12-22 2020-11-24 Chemocentryx, Inc. diaryl-substituted 5.5-fused ring compounds as c5ar inhibitors
EP3936192A4 (en) * 2019-03-06 2022-11-16 Daiichi Sankyo Company, Limited Pyrrolopyrazole derivative
CN112142742B (en) * 2019-06-26 2022-01-07 香港理工大学深圳研究院 CTCF transcription factor inhibitor and application thereof
WO2022155860A1 (en) * 2021-01-21 2022-07-28 Biofront Therapeutics (Beijing) Co., Ltd. Modulators of fpr1 and methods of using the same
WO2022155859A1 (en) * 2021-01-21 2022-07-28 Beijing Tiantan Hospital Modulators of fpr1 and methods of using the same
GB202100976D0 (en) 2021-01-25 2021-03-10 Riotech Pharmaceuticals Ltd Treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4356108A (en) 1979-12-20 1982-10-26 The Mead Corporation Encapsulation process
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5508300A (en) * 1994-01-14 1996-04-16 Pfizer Inc. Dihydro pyrazolopyrroles, compositions and use
RU2320661C2 (en) * 2006-03-15 2008-03-27 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию Российской Федерации" (ГОУ ВПО ПГФА Росздрава) 1,4,5,6-tetrahydro-6-oxo-5-(2-piperazinoethyl)-4-phenyl-3-(4-chlorophenyl)pyrrolo[3.4-c]pyrazole dihydrochloride eliciting hypotensive and anti-coagulant activity
CA2682473A1 (en) * 2007-03-30 2008-10-09 Shionogi & Co., Ltd. Novel pyrrolinone derivative and pharmaceutical composition comprising the same
TW201016702A (en) * 2008-09-25 2010-05-01 Shionogi & Co Novel pyrrolinone derivative and pharmaceutical composition comprising the same
CA2686584A1 (en) * 2009-11-27 2011-05-27 Institut Pasteur Plasmodium proteases inhibitors and in silico screening methods for identifying the same

Also Published As

Publication number Publication date
WO2012046030A3 (en) 2012-08-09
WO2012046030A2 (en) 2012-04-12

Similar Documents

Publication Publication Date Title
HK1254345B (en) Cdk inhibitors
GB201016880D0 (en) Phosphodiesterase inhibitors
HK1201519A1 (en) Inhibitors of phosphodiesterase type 10a 10a
EP2552208A4 (en) Imidazolyl-imidazoles as kinase inhibitors
GB2498145B (en) Releasable corrosion inhibitors
HK1200828A1 (en) Kinase inhibitors
EP2683693A4 (en) Rorgammat inhibitors
EP2710007A4 (en) Kinase inhibitors
EP2552211A4 (en) Indazolyl-pyrimidines as kinase inhibitors
EP2552214A4 (en) Pyrazolyl-pyrimidines as kinase inhibitors
GB201009731D0 (en) Kinase inhibitors
EP2785183A4 (en) Triazolopyridinone pde10 inhibitors
EP2702064A4 (en) Kinase inhibitors
HK1199873A1 (en) Kinase inhibitors
PT3070091T (en) Benzodioxole derivatives as phosphodiesterase inhibitors
EP2521451A4 (en) Hedgehog inhibitors
EP2629616A4 (en) Substituted amino-triazolyl pde10 inhibitors
GB201020798D0 (en) Corrosion inhibitors
ZA201208111B (en) Cytokine inhibitors
EP2642856A4 (en) Integrin-linked kinase inhibitors
GB201018597D0 (en) Inhibitors
GB201006605D0 (en) Novel inhibitors
GB201003936D0 (en) Novel inhibitors
GB201003502D0 (en) Novel inhibitors
GB201120474D0 (en) Inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)